270 related articles for article (PubMed ID: 14728081)
1. Preventing macrovascular disease in patients with type 2 diabetes mellitus.
Johansen OE; Birkeland KI
Am J Cardiovasc Drugs; 2003; 3(4):283-97. PubMed ID: 14728081
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological strategies to reduce cardiovascular risk in type 2 diabetes mellitus: an update.
Hovens MM; Tamsma JT; Beishuizen ED; Huisman MV
Drugs; 2005; 65(4):433-45. PubMed ID: 15733008
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus: a cardiovascular disease.
Candido R; Srivastava P; Cooper ME; Burrell LM
Curr Opin Investig Drugs; 2003 Sep; 4(9):1088-94. PubMed ID: 14582453
[TBL] [Abstract][Full Text] [Related]
4. Multifactorial aspects of the treatment of the type II diabetic patient.
Colwell JA
Metabolism; 1997 Dec; 46(12 Suppl 1):1-4. PubMed ID: 9439550
[TBL] [Abstract][Full Text] [Related]
5. [Type 2 diabetes mellitus and cardiovascular risk factors: is comprehensive treatment required?].
Nadal JF; Gutiérrez PC
Med Clin (Barc); 2013 Sep; 141 Suppl 2():7-13. PubMed ID: 24444518
[TBL] [Abstract][Full Text] [Related]
6. Management of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials.
Yki-Järvinen H
Drugs; 2000 Nov; 60(5):975-83. PubMed ID: 11129129
[TBL] [Abstract][Full Text] [Related]
7. Management of co-existing diabetes mellitus and dyslipidemia: defining the role of thiazolidinediones.
Florkowski CM
Am J Cardiovasc Drugs; 2002; 2(1):15-21. PubMed ID: 14727995
[TBL] [Abstract][Full Text] [Related]
8. [Diabetes mellitus and coronary artery disease. Update on diagnosis and drug therapy].
Marx N; Blessing E
Dtsch Med Wochenschr; 2007 May; 132(19):1034-8. PubMed ID: 17476633
[No Abstract] [Full Text] [Related]
9. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature.
Nalysnyk L; Hernandez-Medina M; Krishnarajah G
Diabetes Obes Metab; 2010 Apr; 12(4):288-98. PubMed ID: 20380649
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice.
Patoulias D; Stavropoulos K; Imprialos K; Athyros V; Doumas M; Karagiannis A
Curr Vasc Pharmacol; 2020; 18(2):125-138. PubMed ID: 32013815
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease morbidity and mortality in patients with type 1 diabetes mellitus : management strategies.
Soedamah-Muthu SS; Stehouwer CD
Treat Endocrinol; 2005; 4(2):75-86. PubMed ID: 15783245
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of cardiovascular disease in type 2 diabetes].
Birkeland KI; Claudi T; Hansteen V; Hanssen KF; Hjermann I; Jenssen T; Jervell J; Os I
Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2554-9. PubMed ID: 11070996
[TBL] [Abstract][Full Text] [Related]
13. Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes.
Bourassa MG; Berry C
Curr Atheroscler Rep; 2008 Apr; 10(2):106-16. PubMed ID: 18417064
[TBL] [Abstract][Full Text] [Related]
14. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
Coccheri S
Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
Otsuki M; Goya K; Kasayama S
Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
[TBL] [Abstract][Full Text] [Related]
16. [Is type-2 diabetes mellitus preventable?].
Jermendy G
Orv Hetil; 2003 Sep; 144(39):1909-17. PubMed ID: 14598569
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
Lebovitz HE
Diabetes Care; 1999 Apr; 22 Suppl 3():C41-4. PubMed ID: 10189561
[TBL] [Abstract][Full Text] [Related]
18. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes mellitus: prevention of macrovascular complications.
Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
[TBL] [Abstract][Full Text] [Related]
20. Crossing family histories of diabetes and cardiovascular disease leads to unexpected outcomes in diabetic offspring.
Hermans MP; Ahn SA; Rousseau MF
J Diabetes; 2019 Apr; 11(4):301-308. PubMed ID: 30105804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
